More than a quarter do not exercise in the week
Skandia International, Fairbairn Private Bank and Axa PPP International scooped big prizes at this year's International Fund & Product awards.
The private medical insurance (PMI) market's two biggest players have seen a rise in the number of complaints escalated to the Financial Ombudsman Service (FOS).
AXA PPP International has introduced a new support service for expat members of its health insurance schemes - ‘MyGlobe'.
Axa PPP has extended its cancer coverage to include the clinically effective prostate cancer drug rejected for the NHS because it is too expensive.
Medical insurance brokers have applauded moves by private medical insurance (PMI) providers to remove the limits on cancer coverage for many standard polices.
Axa PPP has removed all cost and time limits for licensed cancer drug treatment for patients on its standard individual and SME plans.
Fraud is becoming a key target for the health insurance industry as it bids to stem the continued growth in medical inflation.
A new breed of rehabilitation only group risk products is likely to be born if the results of the Sickness Absence Review are followed through, Legal & General has said.
The Association of Medical Insurance Intermediaries (Amii) has warned that 2012 will be another tough year for the private medical insurance (PMI) sector.